Andreas Strasser
Overview
Explore the profile of Andreas Strasser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
311
Citations
26133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
M Bader S, Scherer L, Schaefer J, Cooney J, Mackiewicz L, Dayton M, et al.
Cell Death Differ
. 2025 Feb;
PMID: 40016339
Excessive inflammation and cytokine release are hallmarks of severe COVID-19. Certain programmed cell death processes can drive inflammation, however, their role in the pathogenesis of severe COVID-19 is unclear. Pyroptosis...
2.
Chen T, Ashwood L, Kondrashova O, Strasser A, Kelly G, Sutherland K
Oncogene
. 2024 Nov;
44(3):115-129.
PMID: 39567755
The tumour suppressor gene p53 is one of the most frequently mutated genes in lung cancer and these defects are associated with poor prognosis, albeit some debate exists in the...
3.
Luo M, Tan T, Trussart M, Poch A, Nguyen T, Speed T, et al.
Blood
. 2024 Oct;
144(26):2748-2761.
PMID: 39471335
Venetoclax, a first-in-class BH3 mimetic drug that targets B-cell lymphoma-2 (BCL-2), has improved the outcomes of patients with chronic lymphocytic leukemia (CLL). Early measurements of the depth of the venetoclax...
4.
La Marca J, Kelly G, Strasser A, Diepstraten S
Dev Cell
. 2024 Oct;
59(19):2532-2548.
PMID: 39378839
From its earliest characterization, it has been recognized that there is a role for regulated (programmed) cell death in cancer. As our understanding of the different types of programmed cell...
5.
Lieschke E, Thomas A, Kueh A, Atkin-Smith G, Baldoni P, La Marca J, et al.
EMBO J
. 2024 Aug;
43(19):4406-4436.
PMID: 39160273
Investigating how transcription factors control complex cellular processes requires tools that enable responses to be visualised at the single-cell level and their cell fate to be followed over time. For...
6.
Shi Y, Strasser A, Green D, Latz E, Mantovani A, Melino G
Cell Mol Immunol
. 2024 May;
21(7):790-797.
PMID: 38822079
No abstract available.
7.
Audiger C, Laabi Y, Nie J, Gibson L, Wilson-Annan J, Brook-Carter P, et al.
Cell Rep
. 2024 Apr;
43(5):114159.
PMID: 38676923
The traditional view of hematopoiesis is that myeloid cells derive from a common myeloid progenitor (CMP), whereas all lymphoid cell populations, including B, T, and natural killer (NK) cells and...
8.
Diepstraten S, Yuan Y, La Marca J, Young S, Chang C, Whelan L, et al.
Cancer Cell
. 2024 Apr;
42(5):850-868.e9.
PMID: 38670091
TP53-mutant blood cancers remain a clinical challenge. BH3-mimetic drugs inhibit BCL-2 pro-survival proteins, inducing cancer cell apoptosis. Despite acting downstream of p53, functional p53 is required for maximal cancer cell...
9.
Newton K, Strasser A, Kayagaki N, Dixit V
Cell
. 2024 Jan;
187(2):235-256.
PMID: 38242081
Cell death supports morphogenesis during development and homeostasis after birth by removing damaged or obsolete cells. It also curtails the spread of pathogens by eliminating infected cells. Cell death can...
10.
Theriot J, Simonsen A, Tolic I, Leonetti M, Mayor S, Bassereau P, et al.
Cell
. 2024 Jan;
187(2):219-224.
PMID: 38242078
50 years ago, cell biology was a nascent field. Today, it is a vast discipline whose principles and tools are also applied to other disciplines; vice versa, cell biologists are...